Cannabis Science Inc Institutional Investor Sentiment Improved in 2019 Q2

Cannabis Science, Inc. (OTCMKTS:CBIS) Logo

Sentiment for Cannabis Science Inc (CBIS)

Cannabis Science Inc (CBIS) institutional sentiment 1 in Q2 2019. Its in 2019Q1. The ratio [12345], as 1 active investment managers increased and opened new holdings, while 1 trimmed and sold stock positions in Cannabis Science Inc. The active investment managers in our partner’s database now have: 309,180 shares, down from 389,180 shares in 2019Q1. Also, the number of active investment managers holding Cannabis Science Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 0 Reduced: 1 Increased: 0 New Position: 1.

Cannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phytocannabinoid pharmaceutical products primarily in the United States. The company has market cap of $56.91 million. The firm is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance. It currently has negative earnings. The Company’s drugs under development include CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis therapy for neurological conditions.

It closed at $0.0223 lastly. It is down 0.00% since September 13, 2018 and is . It has by 0.00% the S&P500.

Captrust Financial Advisors holds 0% of its portfolio in Cannabis Science, Inc. for 20,000 shares. Donaldson Capital Management Llc owns 99,780 shares or 0% of their US portfolio. Moreover, Edge Wealth Management Llc has 0% invested in the company for 15,000 shares. The Texas-based Frontier Investment Mgmt Co has invested 0% in the stock. Massmutual Trust Co Fsb Adv, a Connecticut-based fund reported 8,400 shares.

More notable recent Cannabis Science, Inc. (OTCMKTS:CBIS) news were published by: which released: “Marijuana Penny Stocks: What You Need to Know About ACBFF Stock and CBIS Stock – Profit Confidential” on March 12, 2018, also with their article: “Cannabis Science’s Acquisition Raises More Questions Than Answers – Seeking Alpha” published on April 07, 2017, published: “10 Medical Marijuana Stocks to Cure Your Portfolio –” on August 12, 2019. More interesting news about Cannabis Science, Inc. (OTCMKTS:CBIS) were released by: and their article: “Rush for pot patents in full swing – Reuters – Seeking Alpha” published on November 30, 2018 as well as‘s news article titled: “Cannabis One acquires Honu brand – Seeking Alpha” with publication date: April 10, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.